Press Releases

Health News Posted on Friday, November 21, 2014

Premium Press Releases »

Derm-biome Pharmaceuticals' Topical Therapy Shows Positive Results in Preclinical Skin Cancer Trial: Drug Prevents the Development of Precancerous Skin Conditions and Treats Existing Skin Cancers With No Observable Side Effects

VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most common form of precancer, with over 40 ...

Read More

London Research & Pharmaceuticals presents the Advancement of LRP-661, their Oral Cannabidiol Sulphate Drug Candidate at the Prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII Conference in Miami

LONDON, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- London Research & Pharmaceuticals has recently publicized data about its lead compound LRP-661 or Cannabidiol sulphate (CBDS), highlighting its safety, efficacy, bioavailability, and ...

Read More

Press Releases »

Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring

BETHLEHEM, Pa. , Nov. 21, 2014 /PRNewswire/ -- Particle Sciences, Inc (PSI), the leading CDMO for drug eluting devices, has developed and manufactured a new innovative vaginal ring for Ladee Pharma Research Institute (LPRI), the Research and ...

Read More

Viruses' Advantage of Surprise is Lost

Gene Replikin Count Shown to Increase 1-2 Years in Advance of Outbreaks of Influenza (H1N1, H5N1, H7N9, and H3N2), SARS, Mers-CoV, Foot and Mouth Disease, Hand Foot and Mouth Disease, Ebola, Dengue Fever and Chikungunya LONDON , Nov. 21, 2014 ...

Read More

TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014

TRU-D's technology continues to prove superior in comparative UK studies HARROGATE, England , Nov. 21, 2014 /PRNewswire/ --  TRU-D SmartUVC LLC and its UK partners, Rapid Disinfection Services Ltd., will feature their superbug-killing UVC ...

Read More

New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States

SAN MARCOS, Texas , Nov. 21, 2014 /PRNewswire/ -- World Hemp Oil, an importer of oil extracted from industrial hemp containing low THC, announces they are now offering legal, organic oil with high CBD (cannabidiol) that is comparable to ...

Read More

BioSpecifics Technologies Corp. Announces New Data on XIAFLEX® for Peyronie's Disease Presented at SMSNA Scientific Meeting

LYNBROOK, N.Y. , Nov. 21, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX ® (collagenase clostridium histolyticum or CCH) ...

Read More

Assisi Animal Health Provides Advice On How To Keep Dogs With Degenerative Myelopathy Comfortable

PINEHURST, N.C. , Nov. 21, 2014 /PRNewswire-iReach/ -- Assisi Animal Health, developers of the Assisi Loop TM , a non-invasive and non-pharmaceutical healing and pain management device for animals, discusses canine degenerative myelopathy (DM). ...

Read More

Oncology Biosimilars Market to Grow at 29.87% CAGR to 2018

DALLAS, November 21, 2014 /PRNewswire/ -- ReportsnReports.com adds Global Oncology Biosimilars Market 2014-2018 industry research report of 71 pages to the life science intelligence collection of its online library. According to this report, ...

Read More

RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts

Standardized design approach simplifies achievement of Imaging 3.0™ goals MOUNT BRYDGES, Ontario , Nov. 20, 2014 /PRNewswire/ -- RedRick Technologies, a provider of ergonomic radiology workstations, monitor mounting solutions and reading ...

Read More

Kubtec® Announces FDA Approval of the Highest Resolution Low Dose Portable Digital Radiography System for NICU

KUB™ 250 Lowers Radiation Exposure and Cross Contamination for NICUs MILFORD, Conn. , Nov. 20, 2014 /PRNewswire/ -- Kubtec, the foremost developer of low dose digital radiography (DR) systems, today announced FDA approval of the KUB 250, the ...

Read More

Project Innovation Launches the Cancer Medicines Interactive Timeline to Highlight the Need for Continued Cancer Innovation in the U.S.

WASHINGTON , Nov. 20, 2014 /PRNewswire-USNewswire/ -- In recognition of decades of medical progress in the country's fight against cancer, a national group of healthcare stakeholders called the Cancer Innovation Coalition (CIC) today launched ...

Read More

Purdue Pharma L.P. Receives FDA Approval for Hysingla™ ER (hydrocodone bitartrate) Extended-Release Tablets CII, A Once-Daily Opioid Analgesic Formulated with Abuse-Deterrent Properties

WARNING: ADDICTION, ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; AND CYTOCHROME P450 3A4 INTERACTION Addiction, Abuse, and Misuse HYSINGLA ER exposes patients ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.